439TiP ROSETTA Lung-01: A phase III, two-stage trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, plus chemotherapy versus atezolizumab + chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer